BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 36996792)

  • 21. Eribulin in advanced liposarcoma and leiomyosarcoma.
    Setola E; Noujaim J; Benson C; Chawla S; Palmerini E; Jones RL
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):717-723. PubMed ID: 28621163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Cells in the Tumor Microenvironment of Soft Tissue Sarcomas.
    Jumaniyazova E; Lokhonina A; Dzhalilova D; Kosyreva A; Fatkhudinov T
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncostatin M and Nivolumab Affect the Cytotoxic T-Cell Proportions and the Susceptibility to TRAIL-Induced Death in Non-Leukocyte Cell Subpopulations in Soft Tissue Sarcomas.
    Toffanin G; Ozaniak A; Bartolini R; Komarc M; Novysedlak R; Rataj M; Smetanova J; Rosato A; Lischke R; Bartunkova J; Strizova Z
    Pharmacology; 2023; 108(3):274-285. PubMed ID: 36996792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncostatin M: Potential Implications for Malignancy and Metabolism.
    Stephens JM; Elks CM
    Curr Pharm Des; 2017; 23(25):3645-3657. PubMed ID: 28677505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncostatin M: A mysterious cytokine in cancers.
    Masjedi A; Hajizadeh F; Beigi Dargani F; Beyzai B; Aksoun M; Hojjat-Farsangi M; Zekiy A; Jadidi-Niaragh F
    Int Immunopharmacol; 2021 Jan; 90():107158. PubMed ID: 33187910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists.
    Baheti AD; Jagannathan JP; O'Neill A; Tirumani H; Tirumani SH
    Korean J Radiol; 2017; 18(1):94-106. PubMed ID: 28096721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncostatin M: a pleiotropic cytokine in the central nervous system.
    Chen SH; Benveniste EN
    Cytokine Growth Factor Rev; 2004 Oct; 15(5):379-91. PubMed ID: 15450253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncostatin M: Risks and Benefits of a Novel Therapeutic Target for Atherosclerosis.
    Rankouhi TR; Keulen DV; Tempel D; Venhorst J
    Curr Drug Targets; 2022; 23(14):1345-1369. PubMed ID: 35959619
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.